Pancreatic cancer (PC) remains a primary cause of cancer-related deaths worldwide.
| INTRODUC TI ON
Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-related death worldwide, accounting for approximately 4% of all cancer cases with about 330,000 deaths per year. 1 PC has also been highlighted as one of the most aggressive malignancies in digestive system, due largely to late diagnoses, high rate of mortality, as well as an increased potential of metastasis and malignancy. 2 Endothelial cells are a type of heterogeneous cell cluster located in the microvascular capillary beds of various organs, among which human microvascular endothelial cells (HMVECs) are unique yet unrecognizable in phenotype, function and structure. 3 Angiogenesis has been widely implicated in the process of tumour development. 4 Moreover, exosomes derived from PC cells trigger the acceleration of angiogenesis in HMVECs via a dynamin-dependent endocytosis process. 5 Exosomes are extracellular vesicles with a size of 40-150 nm play a functional role in PC therapy. 6 Exosomes secreted by tumours can assume the role of carriers to deliver microRNAs (miRs) into recipient cells in the cancer microenvironment, which has been reported to enhance tumour metastasis and invasion. 7 Both miRs and miR exosomes have been speculated to be promising PC therapeutic targets through the protein transfer-induced target cell reprogramme and binding-triggered signal transduction. 8 miRs are a group of short non-coding RNA molecules with the length of 18-22 nucleotides, which regulate genes associated with cell apoptosis, differentiation and neoplastic transformation. 9 The abnormal expression of miRs has been implicated in the development and progression of a large array of cancers, including that of PC. 10 Additionally, the targeting of miR-27a by the anticancer agent 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) has been reported to diminish its expression leading to an inhibition of tumour cell growth through anti-angiogenic responses. 11 Existing literature has indicated that miR-27a directly targets B-cell translocation gene 2 (BTG2) in gastric cancer cells. 12 BTG2 is an immediate early response protein that has been shown to play a role in DNA damage repair, antiproliferation, cell apoptosis and differentiation, whose elevated level has been identified in the majority of normal tissues, including the pancreas. 13 BTG2 is regarded as a tumour inhibitor in pancreatic ductal adenocarcinoma and has been implicated in the progression and growth of PC under the control of miR-21, miR-23a and miR-27a. 14 
Based
on the aforementioned data, we examined the hypothesis that PC cell-derived exosomes carrying miR-27a influence the angiogenesis of HMVEC through BTG2 in PC. Hence, this study indented to investigate the underlying molecular mechanisms associated with the progression of PC to elucidate more effective therapeutic strategies for PC patients through the use of PC cell-derived exosomes co-cultured with HMVECs.
| MATERIAL S AND ME THODS

| Ethics statement
The study was performed in strict accordance with the recommen- 
| Microarray-based gene expression profiling
Differentially expressed genes (DEGs) were screened by downloading PC-related microarray data (GSE22780, GSE16515, GSE32676 and GSE91035) from the Gene Expression Omnibus (GEO) database (https ://www.ncbi.nlm.nih.gov/geo/) ( Table 1 ). The pre-treatment standardization on gene expression data was performed with the Affy package of R language, 15 and the limma package was applied to screen the DEGs with a heat map subsequently plotted. 16 Gene Expression Profiling Interactive Analysis (GEPIA; http://gepia. predict the miRs that regulate the DEGs, the results of which were compared using jvenn. In addition, two additional PC-related miR data sets (GSE41369 and GSE28955) were analysed to screen differentially expressed miRs. 
| Study volunteer
| Immunohistochemistry
The paraffin-embedded sections of tissue specimens were dehydrated using gradient ethanol and treated with water-bath repair in antigen retrieval buffer. The sections were then incubated with nor- 
| Dual-luciferase reporter gene assay
The binding site between BTG2 and miR-27a was analysed using the biological prediction website (https ://cm.jeffe rson.edu/rna22/ Inter activ e/), which was then verified through the application of a dualluciferase reporter gene assay. A BTG2 dual-luciferase reporter gene vector and mutant (MUT) on binding sites miR-27a and BTG2 were constructed, namely PGLO-BTG2 wild-type (WT) and PGLO-BTG2
MUT. The aforementioned two reporter plasmids were respectively cotransfected with miR-27a mimic and negative control (NC) plasmids into human PC cells. Dual-Luciferase ® Reporter Assay System (E1910, Promega Corporation) was applied for luciferase activity detection.
| Cell treatment
The human pancreatic ductal cell line H6c7, PC cell lines (SW1990, 
| 5-Ethynyl-2'-deoxyuridine (EdU)
Cells at the logarithmic growth phase were seeded into a 96-well plate at the density of 2 × 10 3 -4 × 10 4 cells/well. Transfection was performed 24 hours after the cells had adhered to the wall, with 3 duplicate wells set for each treatment. After 48 hours of transfection, cells were treated with EdU labelling 18 with antifluorescence quenching mounting medium added at a density of 100 μL per well.
The images were photographed under a fluorescence microscope.
Cells with red-stained nucleus were regarded as the positively labelled cells. Finally, 3 power fields were randomly selected to count the number of positive and negative cells under the guidance of a microscope.
| Flow cytometry
Annexin V-fluorescein isothiocyanate/propidium iodide (FITC/PI) double staining kit (556547, Shanghai Shoujia Biotechnology Co Ltd) was employed to detect cell apoptosis following a 24-hours period of transfection. The cells were centrifuged at 715 g for 5 minutes at room temperature, followed by re-suspension with pre-cooled 1× phosphate-buffered saline (PBS). After further centrifugation was performed at 715 g for 5-10 minutes, the cells were suspended with 300 µL of 1× binding buffer. The cells were incubated at room temperature under dark conditions for 15 minutes following a uniform mixture with 5 µL annexin V-FITC. The cells were then added with 5 µL PI and ice-bathed under conditions void of light for 5 minutes. Finally, FITC was subsequently detected at an excitation wavelength of 480 nm and 530 nm with PI detected at an excitation wavelength of more than 575 nm using a flow cytometer (Cube 6, Partec).
| Transwell assay
The pre-cooled Matrigel was diluted using serum-free Dulbecco's modified Eagle's medium (DMEM; 40111ES08, Shanghai Yeasen Biological Technology Co Ltd) at a ratio of 1:2 and settled into the apical chamber of a Transwell chamber (3413, Beijing Unique Biotechnology Co Ltd), followed by incubation for 4-5 hours for solidification. Next, the transfected cells were diluted with 100 μL serum-free medium in order to prepare cell suspension at a concentration of 1 × 10 6 cells/mL, which was then seeded into the apical chamber. Next, 500 μL of DMEM containing 20% FBS was added into the basolateral chamber, with 3 duplicate wells prepared for each treatment. After 24-hours incubation, the Transwell chambers were fixed with 5% glutaraldehyde at 4℃, stained with 0.1% crystal violet for 5 minutes and observed under an inverted fluorescence microscope (TE2000, Nikon). Five fields were randomly selected to acquire images, with the mean value calculated as the number of cells crossing the chambers.
| Exosome extraction and identification
The PANC-1 cells were seeded into a 6-well plate at the density of The magnetic beads as well as the CD63 antibody were incubated with 50 μL PBS for 30 minutes at 37℃ (total volume of 400 μL) and vibrated on a shaking table for 24 hours. Sample blockade was subsequently conducted with FBS at 4℃ for 5 minutes. After 4 consecutive cycles of the aforementioned procedures, the exosomes extracted at 4℃ were incubated with magnetic beads for 24 hours.
Later, each part was added with CD63-polyethylene (PE) antibody and incubated at room temperature for 30 minutes as per the provided antibody instructions. The cells that were not added with an antibody were regarded as the blank control, and the PE-labelled anti-human IgG was regarded as the isotype control. The samples were then loaded followed by detection using a Guava easyCyte™ flow cytometry system. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed in order to determine the expression of miR-27a in the exosomes.
| Co-culture of exosomes and HMVECs
The exosomes dissolved with PBS were mixed with Exo-Red 
| RT-qPCR
Total RNA was extracted from the tissues or cells in strict accordance with instructions on the TRIzol Kit (15596-018, Beijing Solarbio Life Sciences Co Ltd). All primers ( 
| Western blot analysis
Total protein was extracted from both the tissues and cells in strict accordance with the instructions of the efficient radio-immuno- 
| Enzyme-linked immunosorbent assay (ELISA)
An ELISA kit was employed to determine the VEGF level according to the instructions provided by the kit (Imunbio). The known antigen was diluted by carbonate-coated buffer (pH = 9.6) into 1-10 μg/mL and added into a 96-well plate. Next, 0.1 mL diluent was added to each well and allowed to stand at 4℃ overnight. The 
| Tumour xenograft in nude mice
A total of 48 female mice with immune deficiency (aged 4-6 weeks, 
| Immunohistochemistry for detecting microvessel density (MVD)
Microvessel density was determined in the tumour tissues of the nude mice based on the methods used during immunohistochemistry. The primary rabbit antimouse antibody (sc-376975) against MVD was purchased from Santa Cruz Biotechnology. The MVD results were evaluated using the Weidner microvessel count method. 20 Low-power lens (4 × 10) was first used to observe and find the area with the most microvessels, and medium-power lens (20 × 10) was utilized to determine number of vessels stained brown. Five power fields were randomly selected from each pathological section to calculate the mean value as MVD. In the event the mean value ≥MVD threshold, vessels were regarded as MVD positive; however, if the result was opposite to the threshold, the vessels were considered to be MVD negative.
| Statistical analysis
All experimental statistical analyses were conducted using SPSS 
| RE SULTS
| miR-27a might regulate PC by targeting BTG2
R language was applied for analysis of the PC-related microarray data (GSE22780, GSE16515, GSE32676 and GSE91035), and the comparison of the top 400 DEGs from these data sets was conducted based on |log2FoldChange| > 1.0 and P value < .05 (Table S2 ). Afterwards, the Venn map was plotted ( Figure 1A ).
Altered BTG2 expression was identified in these four data sets.
The expression heat map of the top 80 DEGs from GSE32676
( Figure S1 ) and GSE16515 ( Figure S2 ) revealed lower levels of BTG2 in the PC tissues in comparison with the normal tissues.
Based on the expression profile of GSE22780 and GSE91035, poor expression of BTG2 was witnessed in the PC tissues ( Figure 1B&C ). After analysis of GEPIA, low BTG2 levels were identified in the PC tissues ( Figure 1D ). The survival analysis found that PC patients with lower levels of BTG2 presented poor disease-free survival ( Figure 1E ). miRWalk, TargetScan, mirDIP, DIANA and starBase were applied to predict regulatory miRs of BTG2. There were 1173 miRs from miRWalk based on energy < −20, 68 miRs from TargetScan, 21 miRs from miRDIP with the screening threshold set as integrated score > 0.8 and 37 miRs from DIANA according to miTG score > 0.9 (Table S3 ). Based on the prediction results of the Venn map, there were 4 intersection miRs (hsa-miR-27a-3p, hsa-miR-92a-3p, hsa-miR-27b-3p and hsa-miR-92b-3p), which were regarded as the target sources of BTG2 ( Figure 1F ). Accordingly, 62 and 172 differential miRs were selected from PC-related miR microarray data (GSE41369 and GSE2895) ( Table S4 ). The differential expression analysis on microarray data revealed that only hsa-miR-27a-3p was highly expressed in PC among 4 regulatory miRs of BTG2. The expression heat map of GSE41369 is shown in Figure S3 , and the expression of hsa-miR-27a in GSE28955 is illustrated in Figure 1G . Based on the aforementioned results, we speculated that miR-27a could regulate BTG2 in PC. Figure 2B ). The aforementioned results revealed high expression of miR-27a in both the PC tissues and cells.
| miR-27a negatively regulates BTG2 in PC cells
Immunohistochemistry was performed to evaluate the positive level of BTG2 in PC. The results indicated that the positive level of BTG2 was predominately located in the cytoplasm and was brownish in appearance in PC ( Figure 2C ). BTG2-positive level was lower in PC tissues than in pancreatic tissues obtained from patients with pancreatitis (P < .05; Figure 2D ). Online analysis software found a specific binding region between BTG2 and miR-27a sequences (Figure 2E ). To confirm this prediction, dual- 
| miR-27a depletion inhibits proliferation and invasion but promotes apoptosis of PC cells
The 
| miR-27a down-regulation suppresses cell proliferation and invasion and enhances apoptosis in PC by up-regulating BTG2
BTG2-overexpressed plasmids were introduced into the PANC-1 cells for interference of BTG2 level along with miR-27a mimic.
Next, EdU assay, Transwell assay and flow cytometry were performed respectively to measure PANC-1 cell proliferation, invasion and apoptosis. The results indicated that the treatment of BTG2 plasmid led to a decrease in red positive cell proliferation and invasion and an enhancement of apoptosis, while these effects were reversed following co-treatment with miR-27a mimic and BTG2-NC ( Figure 4A-F) . Western blot analysis was employed to detect the protein levels of VEGF, VEGFR, MMP-2 and MMP-9.
The results collected indicated that the protein levels of VEGF, VEGFR, MMP-2 and MMP-9 were inhibited following the treatment of BTG2 plasmid, and it was promoted by the co-treatment of miR-27a mimic and BTG2-NC ( Figure 4G-H) . The aforementioned findings suggested that the down-regulation of miR-27a led to an elevation of BTG2, thus inhibiting cell proliferation, invasion and promoting apoptosis in PC. depletion was found to down-regulate miR-27a ( Figure 5D ).
| Depleted miR-27a inhibits PC occurrence and angiogenesis in vivo
Western blot analysis was performed in order to determine the protein levels of BTG2 and VEGF in tumour tissues of nude mice, which revealed that enhanced VEGF level and suppressed BTG2 level were induced by miR-27a elevation, and the opposite trends were caused by miR-27a silencing ( Figure 5E&F ). Finally, immunohistochemistry was performed to detect MVD in tumour tissues of nude mice. Brownish cells or cell clusters were observed and regarded as the new vessels. Elevated miR-27a led to an increase in MVD, and depleted miR-27a decreased MVD ( Figure 5G&H ). Thus, the results suggested that silencing of miR-27a inhibits the tumorigenesis of PANC-1 cells and reduced MVD in tumour tissues of nude mice.
| PC cells deliver miR-27a into HMVEC via exosomes
TEM analysis revealed that the supernatant of PANC-1 cell culture medium contained exosomes with solid dense bodies, which were generally saucer-shaped or sphere-and vesicle-shaped with a size of 50-200 nm ( Figure 6A ). The flow cytometry was conducted to detect the level of exosome surface marker CD63, the results of which revealed that the exosomes had higher CD63 level, which further indicated that exosomes were successfully extracted ( Figure 6B&C ). RT-qPCR was performed in order to detect the expression of miR-27a in the exosomes extracted from the PANC-1 cells, which indicated that the expression of miR-27a was increased in exosomes from PANC-1 cells in comparison with those from H6c7 cells (P < .05; Figure 6D ). The uptake of exosomes by E and F, Cell apoptosis in PC after the treatment of BTG2 plasmid and the cotreatment of miR-27a mimic and BTG2 plasmid. G and H, Protein levels of VEGF, VEGFR, MMP-2 and MMP-9 after the treatment of BTG2 plasmid and the cotreatment of miR-27a mimic and BTG2 plasmid. *P < .05 vs PANC-1 cells treated with BTG2-NC or both miR-27a mimic and BTG2. The above data are measurement data and described as mean ± standard deviation. Comparisons among multiple groups are analysed by one-way analysis of variance. The experiment was repeated 3 times independently. miR-27a, microRNA-27a; BTG2, B-cell translocation gene 2; PC, pancreatic cancer; NC, negative control; EdU, 5-ethynyl-2'deoxyuridine; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor; MMP, matrix metallopeptidase miR-27a serves as an oncogene in various cancers, and its expression had been found to be up-regulated in PC. 23 A recent study concluded that the down-regulation of miR-27a results in the inhibition of cell growth and invasion as well as the promotion of apoptosis. 24 In addition, BTG2 was verified as the target gene of miR-27a following the detection of luciferase activity and quantification. BTG2 has been reported to be a cancer inhibitor gene and exhibits low levels of expression in tumour tissues, the inhibition of which has been linked with metastasis, invasion and migration of tumour cells. 25 Meanwhile, a prior study has also provided an insight suggesting that there is a decrease in BTG levels in pancreatic ductal adenocarcinoma, indicating that BTG2 is the direct target of cooperative miR-2a, miR-23a and miR-27a. 14 shown to be a critical angiogenesis growth factor that facilitates and maintains vascular endothelial cell proliferation and growth. 27 VEGFs have been shown to have an impact on a large array of cellular processes and initiate the activation of a cascade of downstream signalling pathways, and they do this by interacting with the kinase domain of VEGFRs. 28 MVD has been correlated with the activity of angiogenesis in tumour formation. 29 MMPs, which have also been identified as potential cancer biomarkers, have been speculated to facilitate the disintegration of extracellular matrix components with studies implicating their activity in cancer cell metastasis and invasion. 30 The up-regulation of both MMP-2 and MMP-9, both of which have been shown to play an active role in malignant cell invasion, has been highlighted in PC. 31, 32 Ma Y et al concluded that miR-27a knockdown contributes to the inhibition of cell growth, migration and colony formation in PC. 23 In addition, miR-27a accelerated cancer stem cell differentiation in order to promote angiogenesis in breast cancer. 33 Elevated levels of BTG2 have been implicated in the inhibition of cell proliferation and invasion, along with the F I G U R E 7 PANC-1-exo carrying miR-27a contributes to acceleration of HMEC-1 cell proliferation, invasion and angiogenesis but inhibition of apoptosis. A and B, Positive cell proliferation in HMEC-1 cells in response to the treatment of Exo-depl, PANC-1-exo and miR-27a mimic detected by EdU (200×). C and D, Cell invasion in HMEC-1 cells in response to the treatment of Exo-depl, PANC-1-exo and miR-27a mimic (200×). E and F, Angiogenesis of HMEC-1 cells in response to the treatment of Exo-depl, PANC-1-exo and miR-27a mimic (100×). G and H, Cell apoptosis in HMEC-1 cells in response to the treatment of Exo-depl, PANC-1-exo and miR-27a mimic. I and J, Protein levels of VEGF, VEGFR, MMP-2 and MMP-9 in response to the treatment of Exo-depl, PANC-1-exo and miR-27a mimic. *P < .05 vs the treatment without exosomes or the delivery of Exo-depl. The above data are measurement data and described as mean ± standard deviation. Comparisons among multiple groups are analysed by one-way analysis of variance. The experiment was repeated 3 times independently. miR-27a, microRNA-27a; exo, exosome; EdU, 5-ethynyl-2'-deoxyuridine; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor; MMP, matrix metallopeptidase enhancement of apoptosis of MDA-MB-231 human triple-negative breast cancer cells. 34 The PC cells and HMVEC co-culture system results revealed that PC cell-derived exosomes delivering miR-27a act to promote the proliferation, invasion and angiogenesis of HMVEC. There have been multiple cell-secreted exosomal miRs that have linked to metastasis initiation, resistance to drugs as well as tumour growth. 35 The co-culture of exosomes and HMVEC has been found to induce endothelial dysfunction in patients suffering from acute chest syndrome. 36 Exosomes secreted by cancer cells are widely known with the ability to enter the tumour circulation and microenvironment, highlighting the potential of exosomal miRs as promising biomarkers capable of facilitating the improvement of cancer detection. 37 The aberrant expression of exosomal miR-21 has been detected in PC, which may serve as an early diagnostic marker for PC. 38 Moreover, exosomes containing miR-27a play a functional role in osteosarcoma with different chemotherapy sensitivity. 39 The overexpression of exosomal miR-17-5p has been linked with metastasis and deterioration of PC into advanced stage. 40 Exosomes derived from breast cancer MDA-MB-231 cells have also been found to promote cell proliferation, invasion and migration in breast cancer. 41 Taken together, this study indicates that PC cell-derived exosomes carrying miR-27a have the potential to be a PC therapeutic biomarker due to their promotive effect on the angiogenesis of HMVECs in PC (Figure 8 ). The aforementioned findings provide evidence that miR-27a can function as alternative target in therapy of PC. However, owing to the limitation of such objective conditions as time periods and experimental expenditures, future large-scale studies are required to further elucidate the mechanisms identified in our study, based on which exosomal miRs can be applied to improve treatment outcome of PC.
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